CD44 variants bind to a wide variety of ECM constituents and growth factors which have been shown previously to play different roles in tumour invasion, motility and metastasis (Katagiri et al, 1999), and downregulation of their expression may be pivotal for the metastatic cascade to take place. The gene discussed is CD44; the disease is neoplasm.